124 related articles for article (PubMed ID: 3106195)
1. Frequency analysis of augmented CTL production associated with Corynebacterium parvum-induced tumour regression.
Johnson TR; North RJ
Immunology; 1987 Mar; 60(3):361-6. PubMed ID: 3106195
[TBL] [Abstract][Full Text] [Related]
2. The antimetastatic function of concomitant antitumor immunity. II. Evidence that the generation of Ly-1+2+ effector T cells temporarily causes the destruction of already disseminated tumor cells.
Dye ES
J Immunol; 1986 Feb; 136(4):1510-5. PubMed ID: 3080526
[TBL] [Abstract][Full Text] [Related]
3. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
Germain RN; Williams RM; Benacerraf B
Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
[TBL] [Abstract][Full Text] [Related]
4. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
Bear HD
Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
[TBL] [Abstract][Full Text] [Related]
5. Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815.
Brichard VG; Warnier G; Van Pel A; Morlighem G; Lucas S; Boon T
Eur J Immunol; 1995 Mar; 25(3):664-71. PubMed ID: 7705394
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of the tumor-specific immune response by Corynebacterium parvum.
Scott MT
J Natl Cancer Inst; 1975 Jul; 55(1):65-72. PubMed ID: 808637
[TBL] [Abstract][Full Text] [Related]
7. In vitro antitumor effect of lymphoid cells from Corynebacterium parvum-treated mice: effect of route of C. parvum administration.
Ghaffar A; Cullen RT
J Natl Cancer Inst; 1977 Mar; 58(3):717-20. PubMed ID: 300113
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumour effect in vitro of lymphocytes and macrophages from mice treated with Corynebacterium parvum.
Ghaffar A; Cullen RT; Dunbar N; Woodruff MF
Br J Cancer; 1974 Mar; 29(3):199-205. PubMed ID: 4830143
[TBL] [Abstract][Full Text] [Related]
9. Further analysis of the anti-tumour effect in vitro of peritoneal exudate cells from mice treated with Corynebacterium parvum.
Ghaffar A; Cullen RT; Woodruff MA
Br J Cancer; 1975 Jan; 31(1):15-24. PubMed ID: 1156505
[TBL] [Abstract][Full Text] [Related]
10. [Anti-tumour cytostatic and cytotoxic properties of peritoneal exudate cells of conventional and germ-free mice, stimulated or not by "Corynebacterium parvum" (author's transl)].
Fray A; Moreau C; Thobie N; Ducluzeau R
Ann Immunol (Paris); 1982; 133C(1):33-43. PubMed ID: 7092174
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of the potentiation of specific antitumor immunity by intratumor injection of Corynebacterium parvum.
Miyata H; Himeno K; Nomoto K
Cancer Res; 1983 Oct; 43(10):4670-5. PubMed ID: 6883325
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of anti-tumor action of Corynebacterium parvum. II. Potentiated cytolytic T cell response and its tumor-induced suppression.
Mills CD; North RJ; Dye ES
J Exp Med; 1981 Sep; 154(3):621-30. PubMed ID: 6974215
[TBL] [Abstract][Full Text] [Related]
13. Activation and expansion of cytotoxic T lymphocytes from tumor-draining lymph nodes.
McKinnon JG; Hoover SK; Inge TH; Bear HD
Cancer Immunol Immunother; 1990; 32(1):38-44. PubMed ID: 2126983
[TBL] [Abstract][Full Text] [Related]
14. The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity.
Scott MT; Milas L
Cancer Res; 1977 Jun; 37(6):1673-9. PubMed ID: 870181
[TBL] [Abstract][Full Text] [Related]
15. Failure of Corynebacterium parvum presensitization to modify the antitumor effects of systemic and local therapeutic injections of C. parvum in mice.
Scott MT
J Natl Cancer Inst; 1976 Mar; 56(3):675-7. PubMed ID: 815560
[TBL] [Abstract][Full Text] [Related]
16. Adoptive immunization against an established tumor with cytolytic versus memory T cells. Immediate versus delayed onset of regression.
Dye ES; North RJ
Transplantation; 1984 Jun; 37(6):600-5. PubMed ID: 6427998
[TBL] [Abstract][Full Text] [Related]
17. B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum.
Chen L; McGowan P; Ashe S; Johnston JV; Hellström I; Hellström KE
Cancer Res; 1994 Oct; 54(20):5420-3. PubMed ID: 7522958
[TBL] [Abstract][Full Text] [Related]
18. Conditions favouring the selection of either specific or non specific C. parvum-mediated, systemic antitumour immunity in mice.
Scott MT
Dev Biol Stand; 1977 Apr 13-15; 38():273-6. PubMed ID: 415921
[TBL] [Abstract][Full Text] [Related]
19. Chemical and immunological studies on the cell walls of Propionibacterium acnes strain C7 and Corynebacterium parvum ATCC 11829.
Azuma I; Sugimura K; Taniyama T; Aladin A; Yamamura Y
Jpn J Microbiol; 1975 Aug; 19(4):265-75. PubMed ID: 811835
[TBL] [Abstract][Full Text] [Related]
20. Analysis of cytotoxic T cell responses to intracameral allogeneic tumors.
Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1989 Feb; 30(2):323-9. PubMed ID: 2492486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
